Levels of certain tumor markers as differential factors between bilharzial and non-biharzial bladder cancer among Egyptian patients

Cancer Cell International

Volumn 11, Issue , 2011, Pages

  Metwally, Nadia S ^a   Ali, Sanaa A ^a   Mohamed, Azza M ^a   Khaled, Hussein M ^b   Ahmed, Samia A ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b NATIONAL CANCER INSTITUTE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FRUCTOSAMINE; HYDROXYPROLINE; IMMUNOGLOBULIN E; LACTATE DEHYDROGENASE; PYRUVATE KINASE; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA; XANTHINE OXIDASE;

ADOLESCENT; ADULT; ARTICLE; BLADDER CANCER; BLOOD SAMPLING; CANCER PATIENT; CANCER TISSUE; CONTROLLED STUDY; EGYPT; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL;

EID: 79953705394     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-11-8     Document Type: Article

References (88)

1. Shirai T. Etiology of bladder cancer. Semin Urol 1993, 3:113-116.
2. Abdulamir AS, Hafidh RR, Kadhim HS, Abubakar F. Tumor markers of bladder cancer: The schistosomal bladder tumors versus non-schistosomal bladder tumors. J Exp Clin Cancer Res 2009, 28:27. 10.1186/1756-9966-28-27, 2650688, 19243595.
3. Macvicar AD. Bladder cancer staging. BJU Int 2000, 68(1):111-122.
4. Aboul-Nasr AL, Boutrous SG, Hussien MH. Cairo Metropolitan Egypt Cancer Registry, 1978-1979. IARC Sci Publ 1986, 75:37-41.
5. El-Harvey MA, Amr MM, Abdel-Rahman AB. The epidemiology of schistosomiasis in Egypt: Gharbia Governorate. Am J Trop Med hyg 2000, 62:42-48.
6. Mostafa MH, Sheweita SA, O'Connor PJ. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev 1999, 2:97-111.
7. El-Sebai I. Parasites in the etiology of cancer; bilharziasis and bladder cancer. CA Cancer J Clin 1977, 27:100-106. 10.3322/canjclin.27.2.100, 402987.
8. Yalcin O, Karatas F, Erulas FA. The levels of glutathione peroxidase, vitamins A, E, C, and lipid peroxidation in patients with urothelial carcinoma of the bladder. BJU Int 2004, 93:863-866. 10.1111/j.1464-410X.2003.04729.x, 15050006.
9. Arikan S, Akcay T, Konukoglu D, et al. The relationship between antioxidant enzymes and bladder cancer. Noeoplasma 2005, 52:314-317.
10. Kumar B, Koul S, Khandrika L, et al. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res 2008, 68:1777-1785. 10.1158/0008-5472.CAN-07-5259, 18339858.
11. Barzilai A, Rotman G, Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair 2002, 22:3-25.
12. Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resistance Updates 2004, 7:97-110. 10.1016/j.drup.2004.01.004, 15158766.
13. Naka K, Muraguchi T, Hoshii T, Hirao A. Regulation of reactive oxygen species and genomic stability in hematopoietic stem cells. Antioxid Redox Signal 2008, 10:1883-1894. 10.1089/ars.2008.2114, 18627347.
14. Nishikawa M. Reactive oxygen species in tumor metastasis. Cancer Lett 2008, 266:53-59. 10.1016/j.canlet.2008.02.031, 18362051.
15. Khandrika L, Kumar B, Koul S, Maroni P, Koul HK. Oxidative stress in prostate cancer. Cancer Letters 2009, 282:125-136. 10.1016/j.canlet.2008.12.011, 2789743, 19185987.
16. Fried R, Fried LW. Xanthine oxidase (xanthine dehydrogenase). Methods of Enzymatic Analysis 1974, 2:644-649. Verlag Chemie, Weinheim, Academic Press, London, Bergmeyer HU, 2.
17. Parlin D, Whelan J, Ferlay L, Raymond L, Young J, editors. 1997, IARC, Scientific Publications.
18. Lowry OH, Rosenbrough NJ, Farral AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951, 193(1):265-275.
19. Jamall IS, Finelli VN, QueHee SS. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem 1981, 112:7075.
20. Nabih I, El-Ansary A, Abdel-Galil F, Zayed N. On the factors controlling metabolic integration between schistosoma parasites and their molluscan hosts. J Egyp Ger Soc Zool Invert Zool Parasitol 1998, 26D:87-102.
21. Caboud PG, Wroblewski F. Colorimetric measurement of lactic dehydrogenase activity of body fluids. Am J Clin Phathol 1958, 30(3):234-236.
22. Ibsen KH, Orlando RA, Garratt KN, Hernandez AM, Giorlando S, Nungaray G. Expression of multimolecular forms of pyruvate kinase in normal, benign, and malignant human breast tissue. Cancer Research 1982, 42(3):888-892.
23. Valko M, Rhodes CJ, Moncol J, et al. Free radicals, metals, and antioxidants in oxidative stress - induced cancer. Chem Biol Interact 2006, 160:1-40. 10.1016/j.cbi.2005.12.009, 16430879.
24. Aymelek G, Erten D, Aslan S, et al. Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease. Cell Biol Int 2006, 30:376-380. 10.1016/j.cellbi.2006.02.005, 16616293.
25. Beevi SS, Rasheed MH, geetha A. Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma. Clin Chim Acta 2007, 375:119-132. 10.1016/j.cca.2006.06.028, 16889762.
26. Mohamed AA, Abo-Amou DE, Shehata MA, El-Ashery NE. Glutathione peroxidase and nitric oxide in patients with chronic liver diseases. Egypt J Schistosomiais Infect Endem Dis 2001, 23:27-46.
27. Harrison R. Structure and function of xanthine oxidoreductase: where are we now?. Free Radic Biol Med 2002, 33:774-797. 10.1016/S0891-5849(02)00956-5, 12208366.
28. Gülec M, Akin H, Yüce H, Ergin E, Elyas H, Yalcin O, Akyol O. Adenosine deaminase and xanthine oxidase activities in bladder washing fluid from patients with bladder cancer: a preliminary study. Clin Biochem 2003, 36:193-196. 10.1016/S0009-9120(02)00452-6, 12726927.
29. Kokoglu E, Belce A, Ozyurt E, Tepeler Z. Xanthine oxidase levels in human brain tumors. Cancer Lett 1990, 50:179-181. 10.1016/0304-3835(90)90262-V, 2322931.
30. Kaynar H, Meral M, Turhan H, Keles M, Celik G, Akcay F. Glutathione peroxidase, glutathione - S - transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. Cancer Letters 2005, 227:133-139. 10.1016/j.canlet.2004.12.005, 16112416.
31. Ozturk HS, Karaayvaz M, Kacmaz M, Kavutcu M, Akgul H, Durak I. Activities of the enzymes participating in purine and free-radical metabolism in cancerous human colorectal tissues. Cancer Biochem Biophys 1998, 16:157-168.
32. Durak I, Isik ACU, Canbolat O, Akyol O, Kavutcu M. Adenosine deaminase, 5 nucleotidase, xanthine oxidase, superoxide dismutase and catalase activities in cancerous and non-cancerous human laryngeal tissues. Free Radic Biol Med 1993, 15:681-4. 10.1016/0891-5849(93)90174-S, 8138195.
33. Mohamed AM, Mahmoud SS, Farrag RA. Influence of sativa seeds against liver fibrosis and consequence complications in murine schistosomiasis. Int J Biotech and Biochem 2008, 4(4):325-346.
34. Saydah S, Loria C, Eberhardt M, Brancati F. Abnormal glucose tolerance and the risk of cancer death in the United State. Am J Epidemiol 2003, 157:1092-1100. 10.1093/aje/kwg100, 12796045.
35. Misciagna G, De Michele G, Guerra V, Cisternino AM, Di Leo A, Freudenheim JL. Serum fructosamine and colorectal adenomas. Eur J Epidemoil 2004, 19:425-432.
36. Lapolla A, Traldi P, Fedele C. Importance of measuring product of non-enzymatic glycation of proteins. Clin Biochem 2005, 38:103-115. 10.1016/j.clinbiochem.2004.09.007, 15642271.
37. Vijayan G, Sundaram RC, Bobby Z, Hamide A, Selvaraj N, Dasse NR. Increased plasma malondialdehyde and fructosamine in anemic H pylori infected patients: Effect of treatment. World J Gastroenterol 2007, 13:796-800.
38. Misciagna G, Caruso MG, Trevisan M. Nutrition, metabolism and colorectal cancer. Genes Nutr 2008, 3:15-17. 10.1007/s12263-008-0080-7, 2311498, 18850194.
39. Platek M, Krogh V, Micheli A, Browne R, Meneghini E, Sieri S, Schunemann HJ, Pala V, Barba M, Wilding GE, Berrino F, Muti P. Serum fructosamine and subsequent breast cancer risk: A nested case-control study in the ORDET prospective cohort study. Cancer Epidemiol Biomarkers Prev 2005, 14(1):271-274.
40. Pasanisi P, Venturelli E, Morelli D, Fontana L. Serum insulin - like growth factor-1 and platelet - derived growth factor as biomarkers of breast cancer prognosis. Cancer Epidemiol Biomarkers Prev 2008, 17(7):1719-1722. 10.1158/1055-9965.EPI-07-0654, 18628423.
41. DeBerardinis RJ, Lum JJ, Hatzivassilliou G, Thompson CB. The biology of cancer, metabolic reprogramming fuels, cell growth and proliferation. Cell Metabolism 2008, 7:11-20. 10.1016/j.cmet.2007.10.002, 18177721.
42. DeBerardinis RJ, Sayed N, Ditsworth D, Thompson CB. Brick by brick: metabolism and tumor cell growth. Current Opinion in Genetics and Development 2008, 18:54-61. 10.1016/j.gde.2008.02.003, 2476215, 18387799.
43. Coy JF, Dressler D, Wilde J, Schubert P. Mutations in the transketolase-link gene TKTL1: Clinical implications for neurode generative diseases, diabetes and cancer. Clinical Laboratory 2005, 5:257-273.
44. Kayser G, Kassem A, Sienel W, Uentrop LS, Mattern D, Aumann K, Stickeler E, Werner M, Passlick B, Hausen AZ. Lactate - dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase - like protein 1. Diagnostic Pathology 2010, 5:22-31. 10.1186/1746-1596-5-22, 2861018, 20385008.
45. Wu XZ, Ma F, Wang XL. Serological diagnostic factors for liver metastasis in patients with colorectal cancer. World J Gastroenterology 2010, 16(32):4084-4088.
46. Shonk CE, Majima H, Koven BJ, Boxer GE. Enzyme patterns in human tissues IV: comparison of glycolytic enzymes in surgical biopsies and autopsy specimens. Cancer Res 1966, 26:607.
47. Rama Rao AVSS. A text Book f Biochemistry. 2002, 438. L.K. and S Publishers.
48. Reddy SB, Charle MJ, Raju GJN, Vijayan V, Reddy BS, Kumar MR, Sundareswar B. Trace elemental analysis of carcinoma kidney and stomach by PIXE method. Nucl Instr and Meth 2003, B 207:345.
49. Rautray TR, Vijayan V, Sudarshan M, Panigrahi S. Analysis of blood and tissue in gallbladder cancer. Nuclear Instruments and Methods in Physics Research B 2009, 267:2878-2883.
50. Lai HS, Lee JC, Lee PH, Wang ST, Chen WJ. Plasma free amino acid profile in cancer patients. Seminars in Cancer Biology 2005, 15:267-276. 10.1016/j.semcancer.2005.04.003, 15894488.
51. Heber D, Tchekmedyian NS. Cancer cachexia and anorexia. Nutritional oncology 1999, 537-546. California, Academic Press, Heber D, Blackburn GL, Go VLW.
52. Rossi Fanelli F, Cangiano C, Muscaritoli M, Conversano L, Torelli GF, Cascino A. Tumor - induced changes in host metabolism: a possible marker of neoplastic disease. Nutrition 1995, 11:595-600.
53. Sauer LA, Dauchy RT. Pathways of energy metabolism in cancer. Nutrition and cancer prevention 1996, 128-136. Florida: CRC Press, Watson RR, Mufti SI.
54. Kojima T, Yoshikawa K, Saga S, Yamada T, Kure S, Matsui T, Uemura T, Fujimitsu Y, Sakakibara M, Kodera Y, Kojima H. Detection of elevated proteins in peritoneal dissemination of gastric cancer by analyzing mass spectra data of serum proteins. Journal of Surgical Research 2009, 155:13-17. 10.1016/j.jss.2008.07.024, 19394641.
55. Alexandrakis MG, Moschandrea J, Kyriakoy DS, Alexandraki R, Kouroumalis E. Use of a variety of biological parameters in distinguishing cirrhotic from malignant ascites. J Biol Markers 2001, 16:45-49.
56. Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M. Bilharzial related, organ confined, muscle invasive bladder cancer prognostic value of apoptoisis marker, proliferation markers, P 53, E-Cadherin, epidermal growth factor receptor and Cerb B-2. J Urol 2001, 165:1481. 10.1016/S0022-5347(05)66332-X, 11342901.
57. Ali SA, Saba El-Rigal N, Ahmed SA, Khaled HM. Biochemical alterations in serum of bladder cancer patients with and without schistosomiasis. J Genetic Eng and Biotechnol 2005, 3(1):59-71.
58. Salah LA, Kheireldin AA, Mansour MM, Hussein F. Levels of some serum enzymes in patients with schistosomiasis. Am J Trop Med Hyg 1976, 79:270-277.
59. Ahmed SA. Serum alkaline phosphatase activity during pregnancy and post-partum period in bilharzial Egyptian patients. Egypt J Pharm Sc 1994, 35:605-611.
60. Ozacan A, Mengil A. Effect of oral ethanol treatment on the gamma- GT, ALT and AST enzyme activities in the serum, liver and kidneys and on some total cholesterol and lipid levels in rats. Tur Veterinelik - Ve - Hayvan - Cilik - Dergisi 1998, 22:181-187.
61. Ozares R, Tahan V, Aydin S, Uzun H, Kaya S, Senturk H. N-acetyl-cysteine attenuates alcohol - induced oxidative stress in rats. World J Gastroentrol 2003, 9:791-798.
62. Vecer J, Kvapil M, Sprongl L, Kubátová H, Hoch J, Jech Z, Charvát J. Tissue amino acids in patients with colorectal carcinoma. Vnitr Lek 1998, 44(4):192-4.
63. Scioscia KA, Snyderman CH, Wagner R. Altered serum amino acid profile in head and neck cancer. Nutr Cancer 1998, 30:144-7. 10.1080/01635589809514654, 9589433.
64. VanderJagt DJ, Kanellis GJ, Isichei C, Pastuszyn A, Glew RH. Serum and urinary Amino acid levels in sickle cell disease. J Trop Pediatrics 1997, 43:220-225.
65. Proenza AM, Oliver J, Palou A, Roca P. Breast and lung cancer are associated with a decrease in blood cell amino acid content. J Nutr Biochem 2003, 14:133-138. 10.1016/S0955-2863(02)00225-5, 12742540.
66. Souza ALS, Roffe E, Pinho V, Souza DG, Silva AF, Russo RC, Guabiraba R, Pereira CAJ, Carvalho FM, Barsante MM, Oliveira RC, Fraga LAO, Correa DN, Teixeira MN. Potential role of the chemokine macrophage inflammatory protein 1 α in human and experimental schistosomiais. Infection and Immunity 2005, 73:2515-2523. 10.1128/IAI.73.4.2515-2523.2005, 1087406, 15784598.
67. Marck EV. The Therapeutic effect of the neuropeptide hormone somatostatin on Schistosoma mansoni caused liver fibrosis. BMC Infectious Diseases 2005, 5:45. 10.1186/1471-2334-5-45, 1166555, 15949036.
68. Metwally NS. Potency of Allium sativun and Allium cepa oils against Schistosoma mansoni infection in mice. Egypt J Hospital Med 2006, 23:319-332.
69. Potter JJ, Tankesley LR, Mezey E. Infuence of leptin in the development of hepatic fibrosis produced in mice by Schistosoma mansoni infection and by chronic carbon tetrachloride administration. J Hepatol 2003, 38:281-288.
70. Pellegrino MG, Bluth MH, Smith Norowitz T, et al. HIV type 1-specific IgE in serum of long - term surviving children inhibitis HIV type 1 production in vitro. AIDS Res Hum Retroviruses 2002, 18:363-372. 10.1089/088922202753519142, 11897038.
71. Iskander R, Das PK, Aalberse RC. IgG4 antibodies in Egyptian patients with schistosomiais. Int Arch Allergy Appl Immunol 1981, 66:200-207. 10.1159/000232819, 7287200.
72. Hallgren R, Arrendal H, Hiesche K, Lundquist G, Nou E, Zotterstrom O. Elevated serum immunoglobulin E in bronchial carcinoma: its relation to the histology and prognosis of the cancer. J Allergy Clin Immunol 1981, 67:398-406. 10.1016/0091-6749(81)90086-5, 6164710.
73. Ottesen EA, Poinexter RW, Hussain R. Detection, quantitation and specificity of antiparasite IgE antibodies in human schistomiasis mansoni. Am J Trop Med Hyg 1981, 30:1228-1237.
74. Pidcock NB, Cooper EH, El-Aaser AA, El-Sebai I. Immunoglobulin A, G and E levels in Egyptians with cancer: influence of schistosomiasis. Int J Cancer 1984, 33:771-775. 10.1002/ijc.2910330610, 6735523.
75. Jayapal M, Tay HK, Reghunathan R, Zhi L, Chow KK, Rauff M, Melendez AJ. Genome - wide gene expression profiling of human mast cells stimulated by IgE or FCw RI-aggregation reveals a complex network of genes involved in inflammatory responses. BMC Genomics 2006, 7:201-227. 10.1186/1471-2164-7-201, 1574313, 16899111.
76. Gruber BL. Mast cells in the pathogenesis of fibrosis. Curr Rheumatol Rep 2003, 5:147-153. 10.1007/s11926-003-0043-3, 12628046.
77. Shen DZ. A target role for mast cell in the prevention and therapy of hepatic fibrosis. Medical Hypotheses 2008, 70:760-764. 10.1016/j.mehy.2007.07.042, 17919831.
78. Rubinstein E, Sokal JR, Reisman RE, Arbesman C. Relationship of serum total IgE and cell mediated immunity in patients with Hodgkin's disease. Int Arch Allergy Appl Immunol 1977, 55:439-443. 10.1159/000231955, 591107.
79. Eckschlager T, Prusa R, Hladi Rova M, Radvanska J, Slaby K, Radvansky J. Lymphocyte subpopulations and immunoglobulin levels in Hodgkin's disease survivors. Neoplasma 2004, 51:261-264.
80. Fu SL, Pierre J, Smith-Norowitz TA, Hagler M, Bowne W, Pincus MR, Mueller CM, Zenilman ME, Bluth MH. Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody - dependent cell - mediated cytotoxicity against pancreatic cancer cells. Clinical and Experimental Immunology 2008, 153:401-409. 10.1111/j.1365-2249.2008.03726.x, 2527370, 18803764.
81. Chang JS, Buffler PA, Metayer C, Chokkalingam AP, Patokol J, Kronish D, Wiemeles JL. Maternal immunoglobulin E and childhood leukemia. Cancer. Epidemiol Biomarkers Prev 2009, 18(8):2221-2227.
82. Wahl LM, Kleinman HK. Tumor - associated macrophages as targets for cancer therapy. J NaH Cancer Inst 1998, 90:1583-1584.
83. Palapatt GS, Sutcliffe S, Bastian PJ, Platz EA, Dc Marzo AM, Lsaacs WB, Nelson WG. Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis 2005, 26:1170-1181.
84. Araldi EM, Dellaica, Sogno I, Lorusso G, Garbisa S, Albini A. Natural and synthetic agents targeting inflammation and angiogenesis for chemoprevention of prostate cancer. Curr Cancer Drug Targets 2008, 8:146-155. 10.2174/156800908783769382, 18336198.
85. Haseeb MA, Shirazian DJ, Preis J. Elevated serum levels of TNF-alpha, Stnf-RII in murine schistosomiasis correlate with schistosome oviposition and circumoval granuloma formation. Cytokine 2001, 15:266-269. 10.1006/cyto.2001.0925, 11594791.
86. Torben W, Hailu A. Serum cytokines of the 20 k rad-irradiated Schistosoma mansoni cercariae vaccinated, primary and superinfected Cercopethicus aethiops. Exp Parasitol 2007, 115:121-126. 10.1016/j.exppara.2006.07.004, 16949577.
87. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 2000, 21:49-98. 10.1016/S0098-2997(00)00004-2, 10978499.
88. Booth M, Vennervald BJ, Butterworth AE, Kariuki C, Amaganga C, Kimani G, Mwatha JK, Oteda A, Ouma JH, Dunne DW. Exposure to malaria affects the regression of hepatospleenomegaly after treatment for Schistosoma mansoni infection in Kenyan. BMC Medicine 2004, 2:36-45. 10.1186/1741-7015-2-36, 522803, 15450118.